Lemonade -price touched 189$ where we go next from here ?
LMND Stock, I covered the fundamentals of the stock here:
The company deals with Artificial intelligence software to assess the client’s insurance price and even to assess compensation on claims with minimum human intervention.
The stock got covered by Motley Fool a lot in the last months and in an article on December 31st the article named “Lemonade Says It Now Has Over 1 Million Active users” the stock shot up from 111$ to 186$ - someone must be holding a lot of LMND in Motley Fool because that is the second time that their article made the stock jump, and they cover this stock nonstop 😊
LMND is definitely at the forefront of innovation and I believe will be a major player in the online insurance market in the near future! I signed up with them to check the process of the service and I got a full offer for insurance in less than 5 minutes along with a detailed explanation on the quoted price in my email …nice!
So let's focus on technicals:
-first impulse wave ended at 133$ and then accumulated (side trend) between 105 -133.
-second wave took the price all the way up to 187$.
-correction wave started on the 13th of January and so far bottomed down at 148$ ( 0.382 retracement level).
Once the price hits the new low -could be as low as 133 but as it seems it will not reach that low.
Then it will start the third wave – our first price target is 165$ there we will see some accumulation and a lot of convergence.
When the price finishes the accumulation, it will move up again and this will be our second price target at 187$ - previous ATH.
LMND is traded in a much higher market evaluation but in this market that means nothing, investors are looking at the future potential and not the current EPS.
We are very bullish on the stock and the company and we believe that even the 230$ price target is reachable by mid-2021.
Stay safe and Trade safe from the FDGT.
The company deals with Artificial intelligence software to assess the client’s insurance price and even to assess compensation on claims with minimum human intervention.
The stock got covered by Motley Fool a lot in the last months and in an article on December 31st the article named “Lemonade Says It Now Has Over 1 Million Active users” the stock shot up from 111$ to 186$ - someone must be holding a lot of LMND in Motley Fool because that is the second time that their article made the stock jump, and they cover this stock nonstop 😊
LMND is definitely at the forefront of innovation and I believe will be a major player in the online insurance market in the near future! I signed up with them to check the process of the service and I got a full offer for insurance in less than 5 minutes along with a detailed explanation on the quoted price in my email …nice!
So let's focus on technicals:
-first impulse wave ended at 133$ and then accumulated (side trend) between 105 -133.
-second wave took the price all the way up to 187$.
-correction wave started on the 13th of January and so far bottomed down at 148$ ( 0.382 retracement level).
Once the price hits the new low -could be as low as 133 but as it seems it will not reach that low.
Then it will start the third wave – our first price target is 165$ there we will see some accumulation and a lot of convergence.
When the price finishes the accumulation, it will move up again and this will be our second price target at 187$ - previous ATH.
LMND is traded in a much higher market evaluation but in this market that means nothing, investors are looking at the future potential and not the current EPS.
We are very bullish on the stock and the company and we believe that even the 230$ price target is reachable by mid-2021.
Stay safe and Trade safe from the FDGT.
We are the traders union! we unite to fight together and help each other - we are FREE!
the service is completely free ! join us in the struggle
Available free education on our site :
fdgtacademy.com/
the service is completely free ! join us in the struggle
Available free education on our site :
fdgtacademy.com/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.